Company filings profile · CIK 0001139685

20/20 Biolabs, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for 20/20 Biolabs, Inc. (AIDX): 14 filings in the last 90 days vs 22 in the prior 90 (filing-velocity cooling ↓ · 0.64×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.

Material 8-K events — 20/20 Biolabs, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 18, 2026Item 5.07
Sep 10, 2026Delisting / Listing-Rule Failure
Sep 2, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Aug 19, 2026Item 5.07
Aug 17, 2026Results of Operations (earnings); Financial Statements and Exhibits
Aug 5, 2026Regulation FD Disclosure; Financial Statements and Exhibits
Jul 22, 2026Entry into a Material Agreement; Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Jul 1, 2026Regulation FD Disclosure; Financial Statements and Exhibits
May 26, 2026Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits
May 20, 2026Results of Operations (earnings); Financial Statements and Exhibits
Apr 28, 2026Entry into a Material Agreement; Financial Statements and Exhibits
Apr 1, 2026Results of Operations (earnings); Financial Statements and Exhibits

Watch 20/20 Biolabs, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Apr 6, 20264
Apr 6, 20264
Mar 4, 20264
Feb 23, 20264
Feb 23, 20264
Feb 23, 20264
Feb 23, 20264
Feb 23, 20263
Feb 19, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263
Feb 17, 20263

Recent filings

FiledFormDetail
Sep 18, 20268-K Item 5.07
Sep 10, 20268-K Delisting / Listing-Rule Failure
Sep 2, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Aug 19, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS
Aug 19, 20268-K Item 5.07
Aug 17, 2026424B3 PROSPECTUS SUPPLEMENT
Aug 17, 2026424B3 PROSPECTUS SUPPLEMENT
Aug 17, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Aug 14, 202610-Q QUARTERLY REPORT
Aug 5, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jul 22, 20268-K Entry into a Material Agreement; Delisting / Listing-Rule Failure; Financial Statements and Exhibits
Jul 1, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits
Jun 23, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS
Jun 23, 2026DEF 14A DEFINITIVE PROXY STATEMENT
Jun 1, 2026PRE 14A PRELIMINARY PROXY STATEMENT
May 26, 20268-K Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits
May 21, 2026424B3 PROSPECTUS SUPPLEMENT
May 21, 2026424B3 PROSPECTUS SUPPLEMENT
May 20, 202610-Q QUARTERLY REPORT
May 20, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
May 15, 2026NT 10-Q NOTIFICATION OF LATE FILING
Apr 28, 2026424B3 PROSPECTUS SUPPLEMENT
Apr 28, 2026424B3 PROSPECTUS SUPPLEMENT
Apr 28, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits
Apr 13, 2026424B3 PROSPECTUS
Apr 13, 2026424B3 PROSPECTUS
Apr 10, 2026EFFECT Item ; Item ; Item
Apr 9, 2026EFFECT Item ; Item ; Item
Apr 8, 2026CORRESP
Apr 8, 2026UPLOAD
Apr 6, 20264
Apr 6, 20264
Apr 6, 2026S-1 REGISTRATION STATEMENT
Apr 6, 2026POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
Apr 1, 20268-K Results of Operations (earnings); Financial Statements and Exhibits
Mar 31, 202610-K ANNUAL REPORT
Mar 10, 2026SCHEDULE 13G
Mar 10, 2026SCHEDULE 13D
Mar 4, 20264
Feb 25, 2026SCHEDULE 13G